ARCH Venture Partners is a premier venture capital firm specializing in breakthrough science and company creation, particularly in biotech, life sciences, frontier AI, and advanced computing. ARCH often forms companies before a traditional startup exists, working directly with universities and research institutions. Founder relevance is extremely high for scientists commercializing novel IP, but very low for conventional SaaS, marketplaces, or consumer apps. Pitching ARCH without proprietary science or defensible IP is typically a dead end.